falsefalse

Recent Advances in the Treatment of Advanced HER2+ Breast Cancer: SABCS 2024 - Episode 2

ADCs in HER2-Low Breast Cancer: Insights From DESTINY-Breast04, TROPiCS-02, and TROPION-Breast02

, , , ,

Panelists discuss how clinical trials like DESTINY-Breast04, TROPiCS-02, and TROPION-Breast01 have revolutionized treatment options for HER2-low advanced breast cancer by validating novel targeted therapies and antibody-drug conjugates.

Video Player is loading.
Current Time 0:00
Duration 6:26
Loaded: 0%
Stream Type LIVE
Remaining Time 6:26
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

Video content above is prompted by the following:

  • Provide a brief overview of the treatment landscape for HER2-low advanced breast cancer. Briefly highlight key insights from pivotal trials that have helped shape this treatment space:
  • DESTINY-Breast04
  • TROPiCS-02
  • TROPION-Breast01
x